Reporting owner
Pai Panandiker Kaya Kamlesh
Reporting owner CIK 0002095250 · Chief Commercial Officer
These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
1 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Dec 10, 2025 | LB PHARMACEUTICALS INCEmployee Stock Option (Right to Buy) | Pai Panandiker Kaya Kamlesh | Stock award |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transactions in associated filings
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Trade: | LB PHARMACEUTICALS INCLBRX · company listings | Pai Panandiker Kaya KamleshChief Commercial Officer | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 195,000 | 0Value: 0Currency not specified | View ↗ |
1 transaction on this page. Filing date, newest first.